\-\ Texto\\:\\ \ \(0\)\
\-\ surgery\\ and\\ chemotherapy\ \(1\)\
\-\ plain\\ films\\ and\\ ct\\ show\\ \\ an\\ aggressive\\ lytic\\ lesion\\ in\\ the\\ right\\ humeral\\ head\\ and\\ metaphysis\\ with\\ wide\\ transition\\ zone\\,\\ cortical\\ destruction\\,\\ no\\ significant\\ periostitis\\,\\ and\\ dystrophic\\ calcification\\ but\\ no\\ significant\\ tumor\\ matrix\\.\\ \\ mri\\ shows\\ the\\ mass\\ to\\ be\\ enhancing\\.\ \(0\)\
\-\ fibrosarcoma\ \(14\)\
\-\ aggressive\\ neoplasms\\ such\\ as\\ malignant\\ fibrous\\ histiocytoma\\,\\ plasmacytoma\\,\\ metastasis\\,\\ fibroblastic\\-osteosarcoma\\ and\\ fibrosarcoma\ \(0\)\
\-\ 52\\ yo\\ female\\ with\\ right\\ shoulder\\ pain\ \(1\)\
\-\ fibrosarcomas\\ are\\ rare\\ aggressive\\ tumor\\ that\\ tend\\ to\\ occur\\ in\\ the\\ 3rd\\ to\\ 6th\\ decade\\ of\\ life\\.\\ \\ they\\ occur\\ equally\\ in\\ males\\ and\\ females\\.\\ \\ they\\ may\\ be\\ de\\ novo\\ or\\ a\\ secondary\\ tumor\\ in\\ patients\\ with\\ history\\ of\\ paget\\â\\€\\™s\\,\\ osteonecrosis\\,\\ or\\ history\\ of\\ irradiation\\ and\\ prior\\ chondrosarcomas\\.\\ \\ distribution\\ favors\\ metaphyseal\\ and\\ long\\ tubular\\ bones\\ with\\ femur\\(40\\%\\)\\ and\\ \\ humerus\\ \\(10\\%\\)\\.\\ \\ \ \(0\)\
\-\ radiographic\\ appearance\\ is\\ as\\ described\\ with\\ aggressive\\ lytic\\ features\\.\\ \\ usually\\ little\\ periostitis\\ and\\ tumor\\ matrix\\ is\\ seen\\.\\ \\ they\\ may\\ have\\ pseudocapsules\\ and\\ if\\ very\\ large\\ have\\ necrotic\\ areas\\.\\ \\ \ \(0\)\
\-\ clinically\\,\\ they\\ tend\\ to\\ be\\ aggressive\\ tumors\\ that\\ reoccurs\\ and\\ behaves\\ much\\ like\\ malignant\\ fibrous\\ histiocytomas\\.\ \(0\)\
\-\ this\\ patient\\ under\\ went\\ resection\\ and\\ began\\ chemotherapy\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ aggressive\\:\\ 0\\.10297510925460253\ \(0\)\
\-\ fibrosarcoma\\:\\ 0\\.060851833441884134\ \(0\)\
\-\ they\\:\\ 0\\.0606688891918681\ \(0\)\
\-\ periostitis\\:\\ 0\\.059536253218982434\ \(0\)\
\-\ tend\\:\\ 0\\.04773622177748155\ \(0\)\
\-\ matrix\\:\\ 0\\.04701938084859062\ \(0\)\
\-\ fibroblastic\\-osteosarcoma\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ fibrosarcomas\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ pseudocapsules\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ reoccurs\\:\\ 0\\.04342619913283989\ \(0\)\
\-\ tumor\\:\\ 0\\.039255808898735194\ \(0\)\
\-\ behaves\\:\\ 0\\.03801431593743049\ \(0\)\
\-\ histiocytomas\\:\\ 0\\.03801431593743049\ \(0\)\
\-\ lytic\\:\\ 0\\.037685574750618345\ \(0\)\
\-\ novo\\:\\ 0\\.035497933554346786\ \(0\)\
\-\ chondrosarcomas\\:\\ 0\\.034599797806593315\ \(0\)\
\-\ fibrous\\:\\ 0\\.034031785795636184\ \(0\)\
\-\ occur\\:\\ 0\\.031586666293414174\ \(0\)\
\-\ irradiation\\:\\ 0\\.030790980623177148\ \(0\)\
\-\ favors\\:\\ 0\\.030790980623177148\ \(0\)\
\-\ malignant\\:\\ 0\\.0304302529692542\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.030176805764934634\ \(0\)\
\-\ plasmacytoma\\:\\ 0\\.028668897292672448\ \(0\)\
\-\ dystrophic\\:\\ 0\\.027980414817917975\ \(0\)\
\-\ equally\\:\\ 0\\.027980414817917975\ \(0\)\
\-\ de\\:\\ 0\\.027980414817917975\ \(0\)\
\-\ histiocytoma\\:\\ 0\\.027770761544918976\ \(0\)\
\-\ 6th\\:\\ 0\\.02756966797585368\ \(0\)\
\-\ osteonecrosis\\:\\ 0\\.02591216927328613\ \(0\)\
\-\ metaphyseal\\:\\ 0\\.025132740676168427\ \(0\)\
\-\ decade\\:\\ 0\\.02478487088693713\ \(0\)\
\-\ transition\\:\\ 0\\.024565896687080806\ \(0\)\
\-\ males\\:\\ 0\\.02425467057071858\ \(0\)\
\-\ females\\:\\ 0\\.023424016814877237\ \(0\)\
\-\ paget\\:\\ 0\\.023339807783550635\ \(0\)\
\-\ necrotic\\:\\ 0\\.023016668460960423\ \(0\)\
\-\ little\\:\\ 0\\.022862715044684043\ \(0\)\
\-\ significant\\:\\ 0\\.022638888187726337\ \(0\)\
\-\ wide\\:\\ 0\\.022568531622508565\ \(0\)\
\-\ 52\\:\\ 0\\.022427776093227502\ \(0\)\
\-\ went\\:\\ 0\\.022427776093227502\ \(0\)\
\-\ zone\\:\\ 0\\.022358878349509573\ \(0\)\
\-\ humeral\\:\\ 0\\.022290930949842892\ \(0\)\
\-\ humerus\\:\\ 0\\.021658511409703943\ \(0\)\
\-\ neoplasms\\:\\ 0\\.021426651750304997\ \(0\)\
\-\ began\\:\\ 0\\.021314689922336743\ \(0\)\
\-\ metaphysis\\:\\ 0\\.02094172528324464\ \(0\)\
\-\ 3rd\\:\\ 0\\.02084015243988141\ \(0\)\
\-\ destruction\\:\\ 0\\.020790140757792654\ \(0\)\
\-\ \\%\\:\\ 0\\.019638630870404017\ \(0\)\
\-\ tubular\\:\\ 0\\.019602150330123254\ \(0\)\
\-\ much\\:\\ 0\\.019486236549777467\ \(0\)\
\-\ like\\:\\ 0\\.019486236549777467\ \(0\)\
\-\ be\\:\\ 0\\.019474237290796982\ \(0\)\
\-\ distribution\\:\\ 0\\.018944360218672403\ \(0\)\
\-\ may\\:\\ 0\\.018466289348749988\ \(0\)\
\-\ clinically\\:\\ 0\\.018456227693331363\ \(0\)\
\-\ under\\:\\ 0\\.018394650536857318\ \(0\)\
\-\ life\\:\\ 0\\.018364148220365095\ \(0\)\
\-\ have\\:\\ 0\\.018230917028227506\ \(0\)\
\-\ femur\\:\\ 0\\.018184997263858322\ \(0\)\
\-\ described\\:\\ 0\\.017927924588141228\ \(0\)\
\-\ bones\\:\\ 0\\.01776370576908905\ \(0\)\
\-\ features\\:\\ 0\\.01776370576908905\ \(0\)\
\-\ 40\\:\\ 0\\.017710160585656026\ \(0\)\
\-\ films\\:\\ 0\\.017375622626955484\ \(0\)\
\-\ shoulder\\:\\ 0\\.01696985416669377\ \(0\)\
\-\ rare\\:\\ 0\\.01634655270282412\ \(0\)\
\-\ radiographic\\:\\ 0\\.015977164491570117\ \(0\)\
\-\ tumors\\:\\ 0\\.015811410628918724\ \(0\)\
\-\ metastasis\\:\\ 0\\.015757375991625255\ \(0\)\
\-\ cortical\\:\\ 0\\.01534519630825523\ \(0\)\
\-\ calcification\\:\\ 0\\.015279732110626252\ \(0\)\
\-\ very\\:\\ 0\\.015279732110626252\ \(0\)\
\-\ that\\:\\ 0\\.014541682054766733\ \(0\)\
\-\ long\\:\\ 0\\.014513406457304057\ \(0\)\
\-\ 10\\:\\ 0\\.014190267134713844\ \(0\)\
\-\ areas\\:\\ 0\\.014164271779537274\ \(0\)\
\-\ plain\\:\\ 0\\.013671249816202387\ \(0\)\
\-\ enhancing\\:\\ 0\\.013201741541304234\ \(0\)\
\-\ such\\:\\ 0\\.013159274826802228\ \(0\)\
\-\ resection\\:\\ 0\\.013127663327685807\ \(0\)\
\-\ show\\:\\ 0\\.012921950416214906\ \(0\)\
\-\ usually\\:\\ 0\\.012782897802299307\ \(0\)\
\-\ as\\:\\ 0\\.012734753752651505\ \(0\)\
\-\ yo\\:\\ 0\\.0126667562724274\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.012581412510568749\ \(0\)\
\-\ s\\:\\ 0\\.012072747128643285\ \(0\)\
\-\ appearance\\:\\ 0\\.01203894865386523\ \(0\)\
\-\ \\,\\:\\ 0\\.012001924086973332\ \(0\)\
\-\ head\\:\\ 0\\.01193892271218668\ \(0\)\
\-\ secondary\\:\\ 0\\.011768620524673928\ \(0\)\
\-\ history\\:\\ 0\\.011627729435537767\ \(0\)\
\-\ shows\\:\\ 0\\.011573269456792507\ \(0\)\
\-\ and\\:\\ 0\\.011527670317826798\ \(0\)\
\-\ if\\:\\ 0\\.011422381447195248\ \(0\)\
\-\ patients\\:\\ 0\\.010894456154512443\ \(0\)\
\-\ prior\\:\\ 0\\.010808437301489475\ \(0\)\
\-\ surgery\\:\\ 0\\.010221670267784606\ \(0\)\
\-\ or\\:\\ 0\\.009867219201612883\ \(0\)\
\-\ mri\\:\\ 0\\.009671309630121281\ \(0\)\
\-\ large\\:\\ 0\\.009204642521335368\ \(0\)\
\-\ but\\:\\ 0\\.008977848773564225\ \(0\)\
\-\ right\\:\\ 0\\.00888307102571839\ \(0\)\
\-\ female\\:\\ 0\\.008653991484964698\ \(0\)\
\-\ lesion\\:\\ 0\\.008574163674879088\ \(0\)\
\-\ no\\:\\ 0\\.008477282272943861\ \(0\)\
\-\ to\\:\\ 0\\.00841513514173372\ \(0\)\
\-\ seen\\:\\ 0\\.00831836263580143\ \(0\)\
\-\ in\\:\\ 0\\.008303393697344924\ \(0\)\
\-\ \\(\\:\\ 0\\.007116864297969069\ \(0\)\
\-\ \\)\\:\\ 0\\.007029928001116306\ \(0\)\
\-\ ct\\:\\ 0\\.005888195336906615\ \(0\)\
\-\ mass\\:\\ 0\\.00585448771895352\ \(0\)\
\-\ an\\:\\ 0\\.00582100918366862\ \(0\)\
\-\ are\\:\\ 0\\.005738294938569467\ \(0\)\
\-\ is\\:\\ 0\\.005539810624480055\ \(0\)\
\-\ pain\\:\\ 0\\.00514092693364894\ \(0\)\
\-\ this\\:\\ 0\\.004734666075439079\ \(0\)\
\-\ patient\\:\\ 0\\.0042196646843171825\ \(0\)\
\-\ with\\:\\ 0\\.0028818762583716685\ \(0\)\
\-\ the\\:\\ 0\\.0020430928773934845\ \(0\)\
\-\ a\\:\\ 0\\.00195369360501774\ \(0\)\
\-\ \\.\\:\\ 0\\.0019236201826148228\ \(0\)\
\-\ of\\:\\ 0\\.001721731046275691\ \(0\)\
